nAMD and DME: Transforming Visionary Thoughts to Treatment Applications in Real-World Practice
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
Overview
Provider Statement
This continuing education activity is provided by 
Support Statement
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
Activity Description
Neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) affect millions globally, prompting a need for effective treatments. Anti-vascular endothelial growth factor therapies pose challenges due to frequent clinic visits and injections which impact patient adherence and visual outcomes. Strategies to extend treatment intervals involve the development of new regimens and medications. Real-world data highlight the potential of personalized therapeutic regimens to reduce injection frequency, offering improved fluid control and vision. Ophthalmologists and other healthcare professionals should be knowledgeable of the evolving landscape of treatments, individualized plans, and new delivery systems in retinal diseases to reduce treatment burden, improve patient experience, and enhance visual outcomes. In this CE activity, expert faculty review effective and durable therapeutic regimens that improve best-corrected visual acuity and anatomical parameters in patients with nAMD. They also evaluate how to select the most appropriate treatment regimen for patients with DME that facilitates durable vision gains and reduction of macular leakage.
Target Audience
The intended audience for this activity is comprehensive ophthalmologists and other healthcare professionals involved in the management of patients with nAMD and DME.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Incorporate the use of effective and durable therapeutic regimens that improve best-corrected visual acuity and anatomical parameters in patients with nAMD.
- Select the most appropriate treatment regimen for patients with DME that offers durable vision gains while reducing macular leakage.
Activity Chair
Carl D. Regillo, MD, FACS
Director, Retina Service
Wills Eye Hospital
Professor of Ophthalmology
Thomas Jefferson University
Mid Atlantic Retina
Philadelphia, PA
Faculty
Ferhina S. Ali, MD, MPH, FASRS
Vitreoretinal Specialist
Westchester Medical Center
Assistant Professor
New York Medical College
Valhalla, NY
David Eichenbaum, MD
Director of Research
Retina Vitreous Associates of Florida
Collaborative Associate Professor
Morsani College of Medicine
University of South Florida
St. Petersburg, FL
Planner/Reviewer
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, March 31, 2024, to March 30, 2025.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 of the 4 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
Activity Chair and Faculty report the following relevant financial relationship(s)
Ferhina S. Ali, MD, MPH, FASRS
Consultant: AbbVie/Allergan, Apellis, EyePoint, Genentech, IVERIC bio, OcuTerra, Optomed, Regeneron
Speaker Contracted by Ineligible Company: Apellis, IVERIC bio
David Eichenbaum, MD
Consultant: Alimera, Allergan, Annexon, Apellis, Bausch + Lomb, Coherus, Crinetics, EyePoint, Genentech, lVERIC bio, Kodiak, Novartis, Ocular Therapeutix, Opthea, Outlook, Regeneron, Regenxbio, Revive Therapeutics, Samsara
Speaker Contracted by Ineligible Company: Allergan, Apellis, Bayer, Genentech, IVERIC bio, Regeneron
Independent Research Contractor: 4DMT, Alexion, Allgenesis, Annexon, Aviceda, Bayer, Boehringer Ingelheim, EyePoint, Gemini, Genentech, Gyroscope, Ionis, lVERIC bio, Janssen, Kodiak, Mylan, NGM, Novartis, Ocular Therapeutix, Opthea, ONL, Regeneron, Regenxbio, Unity
Individual Stocks and Stock Options (publicly traded): Janssen, Revive Therapeutics
Carl D. Regillo, MD, FACS
Consultant: 4DMT, Adverum, Alcon, Allergan, Annexon, Apellis, Aviceda, Clearside, Cognition Therapeutics, EyePoint, Genentech, Graybug, IVERIC bio, Janssen, Kodiak, Lineage Cell Therapeutics, Merck, NGM Bio, Novartis, Ocugen, Ocuphire, OcuTerra, Opthea, Ray, Regeneron, Regenxbio, Stealth BioTherapeutics, Théa, Zeiss
Independent Research Contractor: 4DMT, Adverum, Allergan, Annexon, Apellis, Astellas, EyePoint, Genentech, Graybug, Gyroscope, IVERIC bio, Kodiak, Lineage Cell Therapeutics, NGM Bio, Notal Vision, Novartis, Ocugen, Opthea, Regeneron, Regenxbio
Planner/Reviewer reports the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2024 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
Procedures for Reporting Copyright Infringement
If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by contacting our designated copyright agent (as outlined below). To do so, kindly provide the following details:
- Specify the copyrighted work you believe has been infringed upon.
- Describe the work and, if possible, include the location (eg, URL) of an authorized version of the work.
- Share your name, address, telephone number, and, if available, your email address.
- Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
- Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you are either the copyright owner or have the authority to act on behalf of the copyright owner.
- Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.
Our agent for copyright issues relating to this web activity is as follows:
Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
fbantivoglio@vindicocme.com
or call: 856-994-9400, ext. 614
CE Questions?
Contact us at cme@vindicoCME.com